JP2022542803A5 - - Google Patents

Info

Publication number
JP2022542803A5
JP2022542803A5 JP2022502217A JP2022502217A JP2022542803A5 JP 2022542803 A5 JP2022542803 A5 JP 2022542803A5 JP 2022502217 A JP2022502217 A JP 2022502217A JP 2022502217 A JP2022502217 A JP 2022502217A JP 2022542803 A5 JP2022542803 A5 JP 2022542803A5
Authority
JP
Japan
Prior art keywords
polymorph
substantially shown
xrpd pattern
graph
dsc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022502217A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022542803A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/042390 external-priority patent/WO2021011809A1/en
Publication of JP2022542803A publication Critical patent/JP2022542803A/ja
Publication of JP2022542803A5 publication Critical patent/JP2022542803A5/ja
Pending legal-status Critical Current

Links

JP2022502217A 2019-07-17 2020-07-16 (r)-n-(5-(5-イソプロピル-1,2,4-オキサジアゾール-3-イル)-2,3-ジヒドロ-1h-インデン-1-イル)-2-メチル-2h-テトラゾール-5-カルボキサミドの多形 Pending JP2022542803A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962875355P 2019-07-17 2019-07-17
US62/875,355 2019-07-17
PCT/US2020/042390 WO2021011809A1 (en) 2019-07-17 2020-07-16 Polymorphs of (r)-n-(5-(5-isopropyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-2-methyl-2h-tetrazole-5-carboxamide

Publications (2)

Publication Number Publication Date
JP2022542803A JP2022542803A (ja) 2022-10-07
JP2022542803A5 true JP2022542803A5 (cg-RX-API-DMAC10.html) 2023-07-25

Family

ID=71995105

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022502217A Pending JP2022542803A (ja) 2019-07-17 2020-07-16 (r)-n-(5-(5-イソプロピル-1,2,4-オキサジアゾール-3-イル)-2,3-ジヒドロ-1h-インデン-1-イル)-2-メチル-2h-テトラゾール-5-カルボキサミドの多形

Country Status (16)

Country Link
US (1) US12649732B2 (cg-RX-API-DMAC10.html)
EP (1) EP3999181B1 (cg-RX-API-DMAC10.html)
JP (1) JP2022542803A (cg-RX-API-DMAC10.html)
KR (1) KR20220082803A (cg-RX-API-DMAC10.html)
CN (1) CN114667283B (cg-RX-API-DMAC10.html)
AU (1) AU2020315433A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022000523A2 (cg-RX-API-DMAC10.html)
CA (1) CA3144974A1 (cg-RX-API-DMAC10.html)
CL (1) CL2022000089A1 (cg-RX-API-DMAC10.html)
ES (1) ES2982707T3 (cg-RX-API-DMAC10.html)
IL (1) IL289881A (cg-RX-API-DMAC10.html)
MX (1) MX2022000498A (cg-RX-API-DMAC10.html)
NZ (1) NZ784931A (cg-RX-API-DMAC10.html)
PH (1) PH12022550084A1 (cg-RX-API-DMAC10.html)
TW (1) TW202116764A (cg-RX-API-DMAC10.html)
WO (1) WO2021011809A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202006296YA (en) 2018-01-19 2020-08-28 Cytokinetics Inc Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
JP7438148B2 (ja) 2018-06-26 2024-02-26 サイトキネティックス, インコーポレイテッド 心臓サルコメア阻害剤
EP3814343B1 (en) 2018-06-26 2023-01-11 Cytokinetics, Inc. Cardiac sarcomere inhibitors
MX2022000498A (es) 2019-07-17 2022-02-03 Cytokinetics Inc Polimorfos de (r)-n-(5-(5-isopropil-1,2,4-oxadiazol-3-il)-2,3-dihi dro-1h-inden-1-il) -2-metil-2h- tetrazol-5-carboxamida.
CN120712262A (zh) * 2023-03-02 2025-09-26 苏州科睿思制药有限公司 Aficamten的共晶及其制备方法和用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7399866B2 (en) * 2003-01-14 2008-07-15 Cytokinetics, Inc. Compounds, compositions, and methods
US7507735B2 (en) 2004-06-17 2009-03-24 Cytokinetics, Inc. Compounds, compositions and methods
US20060173183A1 (en) 2004-12-31 2006-08-03 Alantos Pharmaceuticals, Inc., Multicyclic bis-amide MMP inhibitors
AU2006284751A1 (en) 2005-09-01 2007-03-08 Array Biopharma Inc. Raf inhibitor compounds and methods of use thereof
WO2007078815A2 (en) * 2005-12-16 2007-07-12 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
US20090192168A1 (en) 2008-01-04 2009-07-30 Alex Muci Compounds, Compositions and Methods
MX2012000437A (es) 2009-07-08 2012-02-21 Chelsea Therapeutics Inc Polimorfos cristalinos estables de la sal dipotasica de acido (s)-2-{2,4-diamono-quizolin-6-il)-etil]-benzoilamino}-4-metilen-p entanodioico.
CA2772275A1 (en) 2009-09-18 2011-03-24 Sanofi (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
US8592426B2 (en) 2011-01-24 2013-11-26 Hoffmann—La Roche Inc. Aryl-benzocycloalkyl amide derivatives
NZ727015A (en) 2012-01-25 2017-12-22 Vertex Pharma Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
US9199945B2 (en) 2013-06-21 2015-12-01 MyoKardia, Inc. Cycloalkyl-substituted pyrimidinedione compounds
EP3151671A4 (en) 2014-06-03 2018-03-07 Sulfagenix, Inc. Methods and compositions for treating nitric oxide deficiency disorders and related conditions
US9902702B2 (en) 2014-07-15 2018-02-27 Bristol-Myers Squibb Company Spirocycloheptanes as inhibitors of rock
DK3356345T3 (da) 2015-09-30 2024-02-12 Max Planck Gesellschaft Heteroaryl-derivater som sepiapterin-reduktase-inhibitorer
EP3156049A1 (en) 2015-10-15 2017-04-19 Alembic Pharmaceuticals Limited Pharmaceutical composition of prasugrel
JP2020526483A (ja) 2017-06-30 2020-08-31 アムジエン・インコーポレーテツド 心筋節活性化剤で心不全を治療する方法
BR112020004800A2 (pt) 2017-09-13 2020-09-24 Amgen Inc. compostos de bisamida ativantes do sarcômero e seus usos
SG11202006296YA (en) 2018-01-19 2020-08-28 Cytokinetics Inc Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
JP7438148B2 (ja) 2018-06-26 2024-02-26 サイトキネティックス, インコーポレイテッド 心臓サルコメア阻害剤
EP3814343B1 (en) 2018-06-26 2023-01-11 Cytokinetics, Inc. Cardiac sarcomere inhibitors
MX2022000498A (es) 2019-07-17 2022-02-03 Cytokinetics Inc Polimorfos de (r)-n-(5-(5-isopropil-1,2,4-oxadiazol-3-il)-2,3-dihi dro-1h-inden-1-il) -2-metil-2h- tetrazol-5-carboxamida.
LT3999180T (lt) 2019-07-17 2024-08-26 Cytokinetics, Inc. (r)-n-(5-(5-etil-1,2,4-oksadiazol-3-il)-2,3-dihidro-1h-inden-1-il)-1-metil-1h-pirazol-4-karboksamido polimorfai
WO2021011808A1 (en) 2019-07-17 2021-01-21 Cytokinetics, Inc. Cardiac sarcomere inhibitor oral formulations
EP4370116B1 (en) 2021-07-16 2025-01-15 Cytokinetics, Inc. Aficamten dosage regimens for treating obstructive hypertrophic cardiomyopathy
JP2024530111A (ja) 2021-08-03 2024-08-16 サイトキネティックス, インコーポレイテッド アフィカムテンを調製するための工程
US20240091203A1 (en) 2022-07-20 2024-03-21 Cytokinetics, Incorporated Methods for treating non-obstructive hypertrophic cardiomyopathy
JP2025525913A (ja) 2022-08-04 2025-08-07 サイトキネティックス, インコーポレイテッド 閉塞性肥大型心筋症を治療するための方法
WO2024134498A1 (en) 2022-12-22 2024-06-27 Assia Chemical Industries Ltd. Solid state forms of aficamten and process for preparation thereof
WO2024182469A1 (en) 2023-02-28 2024-09-06 MyoKardia, Inc. Myosin inhibitors for use in the treatment of hypertrophic cardiomyopathy
CN120712262A (zh) 2023-03-02 2025-09-26 苏州科睿思制药有限公司 Aficamten的共晶及其制备方法和用途
WO2025220034A1 (en) 2024-04-16 2025-10-23 Dr. Reddy’S Laboratories Limited "amorphous solid dispersion of aficamten and process for their preparation"

Similar Documents

Publication Publication Date Title
JP2022540668A5 (cg-RX-API-DMAC10.html)
JP2021511331A5 (cg-RX-API-DMAC10.html)
JP4422477B2 (ja) ヘテロアリールスルホニル側鎖を有するアントラニル酸アミド、その製造方法、その医薬または診断助剤としての使用、およびこの化合物を含有する医薬製剤
CN110357789B (zh) 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途
JP2021535164A5 (cg-RX-API-DMAC10.html)
JP2021529185A5 (cg-RX-API-DMAC10.html)
JP2024508526A5 (cg-RX-API-DMAC10.html)
TW200300760A (en) 5-Sulphanyl-4H-1,2,4-triazole derivatives and their use as a medicament
TW202021952A (zh) 製備pde4抑制劑之方法
CN106795099A (zh) 用于治疗高血压和心血管疾病的新型前药和组合物
TW201031645A (en) Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof
CN105218448A (zh) 一种1-甲基-3-二氟甲基-4-吡唑甲酸的合成方法
HUP0203444A2 (hu) (S)-2-Etoxi-3-[4-{2-[4-(metánszulfonil-oxi)-fenil]-etoxi}-fenil]-propionsav kristályos formája, eljárás az előállítására, ezt tartalmazó gyógyszerkészítmény és alkalmazása
JP2019523273A (ja) ベリノスタットの多形形態、およびその調製のためのプロセス
JP2011527330A (ja) スニチニブリンゴ酸塩の結晶形の調製方法
EP2707364A1 (en) Process for the manufacture of dabigatran etexilate and intermediates thereof
US20010031878A1 (en) Novel processes for making- and a new crystalline form of- leflunomide
JP2022540678A5 (cg-RX-API-DMAC10.html)
CN105523999B (zh) 一种达比加群酯中间体的合成方法
TW201120019A (en) New 2-aminothiadiazole derivatives
JP2024546844A5 (cg-RX-API-DMAC10.html)
WO2004000813A1 (ja) フェノキシピリジン誘導体又はその塩
US11339145B2 (en) Synthesis of cerdulatinib
JP2007535512A (ja) 新規なβ−アゴニスト、その製造方法及びその薬物としての使用
CN111592500A (zh) ARB-NEPi复合物、晶型、制备方法及应用